NVOH · ARCA · ETF
Novo Nordisk A/S B Shares ADRhedged (NVOH) Price, Holdings & Fees
Novo Nordisk A/S B Shares ADRhedged (NVOH) closed at $755.07 on Oct 9, 2026, down 0.65% from the previous close of $760.02.
Share price, past year
1Y +23.57%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $755.07 |
| Sep 30, 2026 | $772.97 |
| Aug 31, 2026 | $768.80 |
| Jul 31, 2026 | $789.16 |
| Jun 30, 2026 | $723.52 |
| May 29, 2026 | $742.23 |
| Apr 30, 2026 | $686.04 |
| Mar 31, 2026 | $721.21 |
| Feb 27, 2026 | $685.38 |
| Jan 30, 2026 | $653.61 |
| Dec 31, 2025 | $644.29 |
| Nov 28, 2025 | $637.73 |
| Oct 31, 2025 | $639.82 |
Key statistics
- Expense ratio
- 0.19%
- as of Apr 30, 2026
- Net assets
- $4.2M
- as of Jun 30, 2026
- Holdings
- 3
- as of Jun 30, 2026
- 52-week range
- $611.07 – $794.17
Novo Nordisk A/S B Shares ADRhedged's expense ratio is 0.19%: $19.00 a year on $10,000 invested.
Holdings
Novo Nordisk A/S B Shares ADRhedged held 3 investments worth $4.17M as of Jun 30, 2026. Its largest holding was NOVO NORDISK A/S, at 96.87% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | NOVO NORDISK A/SNVO | 96.87% | $4.04M |
| 2 | DREYFUS TRSRY SECURITIES | 2.79% | $116.46K |
| 3 | CANADIAN IMPERIAL BANK OF COMMERCE | −0.08% | −$3.15K |
Top 3 of 3 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 96.87% |
| Cash and short-term investments | 2.79% |
| Currency derivatives | −0.08% |
| Country | % of fund |
|---|---|
| Denmark | 96.87% |
| United States | 2.79% |
| Canada | −0.08% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jun 30, 2026, Novo Nordisk A/S B Shares ADRhedged's total return was +30.44%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jun 30, 2026 | +7.23% |
| May 31, 2026 | +8.36% |
| Apr 30, 2026 | +12.26% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- Novo Nordisk A/S B Shares ADRhedged
- Ticker
- NVOH
- Exchange
- ARCA
- Fund type
- ETF
- Trust
- Precidian ETFs Trust
- SEC series ID
- S000058687
- SEC CIK
- 0001499655
- Fractional shares
- No
Recent SEC filings
- Aug 21, 2026
- Sep 4, 2026
- 485BPOSProspectus updateApr 29, 2026
- Mar 5, 2026
- Aug 28, 2025
- 485BPOSProspectus updateApr 30, 2025
- Mar 7, 2025
- 485BPOSProspectus updateFeb 28, 2025
Shareholder reports and prospectuses are filed by Precidian ETFs Trust, the trust behind Novo Nordisk A/S B Shares ADRhedged, and cover all of its funds.
Frequently asked questions
What is NVOH's price?
Novo Nordisk A/S B Shares ADRhedged (NVOH) closed at $755.07 on Oct 9, 2026, down 0.65% from the previous close of $760.02.
What is NVOH's expense ratio?
Novo Nordisk A/S B Shares ADRhedged's expense ratio is 0.19%: $19.00 a year on $10,000 invested.
What does NVOH hold?
Novo Nordisk A/S B Shares ADRhedged held 3 investments worth $4.17M as of Jun 30, 2026. Its largest holding was NOVO NORDISK A/S, at 96.87% of the fund. Its five largest holdings were NOVO NORDISK A/S, DREYFUS TRSRY SECURITIES, CANADIAN IMPERIAL BANK OF COMMERCE.
How has NVOH performed?
Over the 3 months to Jun 30, 2026, Novo Nordisk A/S B Shares ADRhedged's total return was +30.44%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 21, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Apr 30, 2026. Prices are generated sample data for development. Data sources and disclosures